Nutex Health Inc Stock Price, News & Analysis

Nutex Health Inc. (NASDAQ: NUTX), a physician-led healthcare delivery system, has been added to both the Russell 3000® Index and Russell Microcap® Index, effective June 30, 2025. This inclusion is part of the 2025 Russell indexes reconstitution, which captures the 4,000 largest U.S. stocks by market capitalization.

The company operates 24 micro hospitals and hospital outpatient departments across 11 states. Membership in these indexes, which remains in place for one year, provides automatic inclusion in other Russell indexes and their corresponding growth and value style indexes. Notably, approximately $10.6 trillion in assets are benchmarked against Russell US indexes as of June 2024.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals and HOPDs across 11 states, has announced the internet availability of proxy materials for its 2025 Annual Meeting. The virtual meeting will be held on July 14, 2025, at 10:00 am Central Time via www.virtualshareholdermeeting.com/NUTX2025. The company is utilizing the 'notice only' option for proxy material delivery, mailing notices to stockholders starting June 2, 2025. Shareholders can access materials online or request paper/email copies through ProxyVote.com, by calling 1-800-579-1639, or emailing sendmaterial@proxyvote.com. This administrative announcement details the process for accessing annual meeting materials and voting procedures.

Nutex Health (NASDAQ: NUTX) reported strong Q1 2025 financial results, with total revenue surging 213.8% to $211.8 million compared to $67.5 million in Q1 2024. The company achieved net income of $14.6 million versus a net loss of $0.4 million in Q1 2024, resulting in diluted EPS of $2.56. EBITDA increased by 507% to $43.1 million, while Adjusted EBITDA reached $72.8 million. The company's success was largely driven by arbitration efforts through the Independent Dispute Resolution process, contributing $105 million in additional revenue. Hospital division visits increased by 20.5% to 48,269, and the company maintained a strong financial position with $87.7 million in cash and cash equivalents. Notable achievements include record-high gross profit of 56% and $51.0 million in net cash from operating activities.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare delivery system operating 24 micro hospitals across 11 states, has announced its schedule for the release of Q1 2025 financial results. The company will release its financial results for the quarter ended March 31, 2025, after market close on Tuesday, May 13, 2025.

A conference call to discuss the results is scheduled for Wednesday, May 14, 2025, at 10:30 a.m. ET. Participants can join via phone (1-877-407-9208 or 1-201-493-6784) or through a dedicated online link. For those unable to attend live, a recording will be available on the company's website.

Nutex Health (NASDAQ: NUTX) reported strong financial results for FY2024, with total revenue reaching $479.9 million, up 93.8% from $247.6 million in 2023. The company achieved a significant turnaround with net income of $52.2 million compared to a net loss of $45.8 million in 2023, resulting in diluted EPS of $9.71.

Key highlights include EBITDA of $98.4 million and Adjusted EBITDA of $123.7 million, representing a 1,045.4% increase from 2023. The Hospital Division recorded 168,388 total visits, up 16.9% year-over-year. The company's arbitration efforts through the Independent Dispute Resolution process contributed significantly, resulting in approximately $169.7 million more in revenue compared to 2023.

As of December 31, 2024, Nutex Health maintained a strong balance sheet with total assets of $655.3 million, including $43.6 million in cash and cash equivalents, and long-term debt of $22.5 million. The company operates 24 micro hospitals and hospital outpatient departments across 11 states.

Nutex Health (NASDAQ: NUTX) has announced the rescheduling of its fourth quarter and full year 2024 financial results release and conference call. The company has moved the earnings release from March 27 to March 31, 2025 (after market close), with the conference call now scheduled for April 1, 2025 at 10:30 a.m. ET.

The company stated it is utilizing the full time allowed by regulations to complete its year-end reporting process. Investors can access the conference call through the dial-in numbers 1-877-407-9208 or 1-201-493-6784, with a recording to be made available on the company's website for those unable to attend live.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro-hospitals across 11 states, has announced its participation in the EDPMA Solutions Summit 2025. CEO Dr. Tom Vo will deliver a presentation titled 'The Evolution of Micro Hospitals and How it Impacts Future Healthcare' on Tuesday, April 1, 2025, from 11:50 AM to 12:30 PM MT at The Broadmoor in Colorado Springs.

The presentation will take place in Broadmoor Hall DE, where management will also engage with industry leaders and healthcare disruptors. The Solutions Summit, focusing on emergency medicine business, will address key topics including:

• The No Surprises Act
• Reimbursement and Regulatory Policy
• Independent Dispute Resolution
• Revenue Cycle Management

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals across 11 states, has announced its upcoming financial results release schedule. The company will disclose its Q4 and full-year 2024 financial results after market close on March 27th, 2025.

A conference call to discuss these results is scheduled for March 28th, 2025, at 10:30 am ET. Participants can join via phone (1-877-407-9208 or 1-201-493-6784) or through a webcast link. Those unable to attend can access the recording on the company's website.

Nutex Health (NASDAQ: NUTX) provided an update on its No Surprises Act (NSA) arbitration strategy implemented in July 2024. The company, which operates 24 micro-hospitals across 11 states, has achieved significant success with its Independent Dispute Resolution (IDR) process, submitting 60-70% of billable visits to arbitration monthly and maintaining an 80% success rate in Q4 2024.

The company partnered with a third-party vendor to recover underpaid out-of-network claims through arbitration. While the process involves substantial upfront costs and administrative delays, Nutex is beginning to realize the cash impact of these efforts. However, the company cautions that future success rates and claim recoveries are not guaranteed, citing potential regulatory changes and evolving arbitration practices as risk factors.